Investigators analysed de-identified data from the Sri Lanka STEPS 2021 survey, a nationally representative cross-sectional study of adults aged 18–69. The weighted analysis included 4,634 participants with blood pressure measurements; the mean age was 43.5 years and 54.8% were female. The study team defined hypertension as systolic BP ≥140 mmHg, diastolic BP ≥90 mmHg, or current antihypertensive use, and used the mean of the last two of three readings as the index BP.
Data indicated a population prevalence of hypertension of 37.2% (CI 35.5–38.9%). A striking diagnostic gap emerged: 60.0% (weighted CI 58.1–63.4) of people who met criteria for hypertension had not been previously diagnosed. The survey also found that 19.3% of participants reported never having checked their blood pressure at least once in their lifetime, with a higher proportion among men. These findings point to both high disease burden and incomplete detection in the community.
Among participants classified as previously diagnosed with hypertension, 73.6% (69.6–77.2%) reported being on antihypertensive medication. Treatment uptake was similar in females and males; the investigators reported no significant sex difference for treated hypertension (p = 0.398). Despite relatively high treatment coverage among those diagnosed, only 38.0% (33.5–42.7%) of treated patients achieved the BP goal of <140/90 mmHg.
Mean systolic and diastolic pressures were lower in females than males. The study team noted no significant sex differences in overall prevalence, treatment uptake, or control rates — but control remained suboptimal across the board.
Complex-samples logistic regression adjusted for age, sex, education, wealth, diabetes, hyperlipidaemia, overweight/obesity, smoking, waist circumference and estimated 24-hour urinary sodium excretion identified multiple correlates of hypertension in the pooled sample. Increasing age, hyperlipidaemia, overweight/obesity (using Asian BMI cutoffs), and larger waist circumference were positively associated with prevalent hypertension. Higher wealth quintile showed a negative association with hypertension prevalence in the pooled model.
When the team stratified by sex, differences emerged. In females, hypertension associated with age, diabetes, hyperlipidaemia, overweight/obesity and waist circumference. In males, hypertension associated with age, wealth quintile, hyperlipidaemia, overweight/obesity, waist circumference and estimated 24-hour urinary sodium. The investigators reported that diabetes was associated with hypertension only in females (p < 0.001), while wealth quintile (p < 0.001) and 24-hour urinary sodium excretion (p = 0.011) were associated only in males.
The study team examined factors linked to being undiagnosed among those with hypertension. In the pooled sample, undiagnosed hypertension correlated with increasing age, higher wealth quintile, the presence of diabetes and hyperlipidaemia, and higher sodium intake estimated from spot urine using the Kawasaki equation. Current smoking showed a negative association with undiagnosed hypertension in adjusted models.
Sex-stratified analyses revealed additional nuance. In females, undiagnosed hypertension associated with age, diabetes and hyperlipidaemia. In males, undiagnosed hypertension associated with age, diabetes, hyperlipidaemia, overweight/obesity and current smoking; the authors specifically reported overweight/obesity as significantly associated with undiagnosed hypertension in males (p = 0.017). Overall, the proportion of hypertensives who were previously undiagnosed was higher in men (69.4%, CI 65.3–73.1) than women (53.6%, CI 50.1–57.0) (p < 0.001).
Field teams included medical and nursing graduates who measured blood pressure with validated digital automatic devices and appropriate cuffs. Three measurements were taken three minutes apart after a 15-minute rest; the mean of the last two readings was used. Body mass index was calculated and Asian BMI cutoffs (≥23 kg/m2) defined overweight/obesity. Spot urine samples were collected and 24-hour sodium excretion estimated by the Kawasaki equation. The STEPS 2021 sampling used multistage stratified cluster methods with 644 primary sampling units and applied STEP2 survey weights to generate population estimates. Statistical analyses used IBM SPSS complex-samples modules and two-sided tests with p≤0.05 considered significant.
The authors reported a complete-case analysis and did not impute missing data; this choice may affect estimates if missingness was non-random. The source did not report details on specific antihypertensive drug classes, dosing, adherence measures or longitudinal clinical outcomes. The survey also used estimated 24-hour sodium from spot urine via the Kawasaki equation rather than measured 24-hour collections; this method has known limitations. Finally, the cross-sectional design prevents causal inference.
Remaining questions documented by the investigators include how to close the diagnostic gap—especially among men—and how to increase the proportion of treated patients achieving BP targets. The source did not report programmatic steps tested to address these gaps, nor did it provide data on medication adherence interventions or district-level implementation outcomes.